The short version of lyophilized powder fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2026-01-28 and is reviewed periodically as new material appears.
In the scientific literature, AOD-9604 appears in reviews of growth hormone fragments and in discussions of peptide-based metabolic research. Some sources distinguish it from growth hormone itself, while others group it with compounds marketed for weight management. The evidence base is small compared with approved obesity medications. Questions about long-term efficacy and clinical relevance remain open, and independent replication of key findings is limited. Most published reports are early-stage and exploratory.
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It is often described as hGH fragment 176-191. Research interest arose because it was designed to isolate possible effects on fat metabolism from other actions of growth hormone. It is not a full growth hormone molecule. Its development history includes early laboratory and animal studies followed by human trials. The peptide has been examined in laboratory, animal, and limited human studies.
The compound has been studied as a potential treatment for obesity and related metabolic conditions. Published trials have examined changes in body weight, fat mass, and safety markers over limited durations. Results have been mixed or modest, and no large-scale outcome trials are established. Regulatory agencies in several countries have not approved it as a therapeutic drug. Some commercial products have been marketed outside regulated pharmaceutical channels, which raises questions about quality and claims.
Research interest in AOD-9604 often focuses on whether it can influence lipid metabolism without the growth-promoting or glucose-related effects of full-length hGH. This question remains unresolved, and findings depend on model, dose, and measurement method. Some reviews treat the peptide as a historical obesity candidate rather than an active therapeutic. Others cite it in discussions of peptide fragments, metabolic signaling, and performance-enhancing substances. Clear conclusions are limited by the small number of rigorous, independent human studies.
AOD-9604 has been investigated primarily as a potential treatment for obesity and related metabolic conditions. Early laboratory work examined its effects on fat cells, and later studies moved into animal models and human clinical trials. Some trials reportedly reached Phase II, but the program did not lead to an approved medicine. Published summaries often note that weight-loss results were modest or inconsistent. The full trial data are not all publicly available in detail.
| Property | Value | Notes |
|---|---|---|
| Common synonym | hGH fragment 176-191 | Refers to the C-terminal segment |
| Appearance | White to off-white powder | Typically supplied lyophilized |
| Solubility | Soluble in water and aqueous buffers | Confirm with technical data |
| Typical storage temperature | -20 °C for dry powder | Protect from moisture and light |
| Common analytical method | RP-HPLC with UV detection | Often paired with mass spectrometry |
Researchers have studied the fragment in cell and animal models to understand its metabolic actions. Some experiments report effects on fat breakdown and fat storage pathways, but the underlying mechanism remains incompletely defined. AOD-9604 does not appear to stimulate the same broad growth hormone receptor signaling as full-length hGH. Whether its observed activities arise from direct receptor interactions or downstream metabolic changes is an open question. Results from different assays are not always consistent.
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to residues 176-191 of the 191-amino-acid hGH sequence. The fragment is not the full hormone and lacks the receptor-binding region associated with growth and metabolic effects of hGH. Researchers developed it to isolate a specific portion of hGH for study. Its exact sequence and length are often stated in peptide catalogs and patents.
The peptide is frequently described as a growth hormone fragment, although it is chemically distinct from full-length hGH. AOD-9604 contains 16 amino acids and includes two cysteine residues that can form an intramolecular disulfide bond. In solution, this structural feature can influence folding, aggregation, and stability. Published descriptions sometimes call it hGH 176-191 or AOD9604, with spacing and capitalization varying. Such naming differences can complicate literature searches, database entries, and product verification.
Identity and purity are commonly checked with reversed-phase high-performance liquid chromatography and mass spectrometry. RP-HPLC separates the peptide from related impurities and can estimate purity by peak area. Mass spectrometry confirms molecular mass and helps detect sequence variants or truncations. Some laboratories use amino acid analysis or peptide mapping for additional characterization. No single method proves biological activity; these techniques establish chemical identity and purity only. They also require suitable reference standards for confident comparison.
Commercial AOD-9604 may vary in purity, counterion content, and residual moisture. Certificates of analysis often report HPLC purity, mass confirmation, and appearance, but testing methods differ between suppliers. Independent verification is sometimes used because labeled content may not match actual peptide amount. Stability under different pH and temperature conditions is not fully standardized across studies. Researchers generally treat lyophilized material as the reference form for weighing and reconstitution. Moisture content can affect accurate mass measurement.
AOD-9604 is typically supplied as a lyophilized white to off-white powder. In this form, it is relatively stable when kept cool, dry, and protected from light. Common storage recommendations place it at −20 °C or below for long-term retention. Reconstituted solutions are less stable and are often kept at 2–8 °C for short periods. Freeze-thaw cycles should be minimized because they can promote aggregation or loss of peptide content. Vials are usually sealed under inert gas to reduce oxidation.
greater flexibility of meal times, carbohydrate quantities, and physical activities, and better glycemic control to reduce the incidence and severity of the complications of diabetes. Major disadvantages of intensive/flexible therapy are that it requires greater amounts of education and effort to achieve the goals, and it increases the daily cost for glucose monitoring four or more times a day. This cost can substantially increase when the therapy is implemented with an insulin pump and/or continuous glucose monitor. It is a common notion that more frequent hypoglycemia is a disadvantage of intensive/flexible regimens. The frequency of hypoglycemia increases with increasing effort to achieve normal blood glucoses with most insulin regimens, but hypoglycemia can be minimized with appropriate glucose targets and control strategies. The difficulties lie in remembering to test, estimating meal size, taking the meal bolus and eating within the prescribed time, and being aware of snacks and meals that are not the expected size. When implemented correctly, flexible regimens offer greater ability to achieve good glycemic control with easier accommodation to variations of eating and physical activity. A 2020 Cochrane systematic review did not find enough evidence of reduction of cardiovascular mortality, non-fatal myocardial infarction or non-fatal stroke when comparing insulin to metformin monotherapy.
=== In the food industry === In the food industry, tyrosinase inhibition is desired as tyrosinase catalyzes the oxidation of phenolic compounds found in fruits and vegetables into quinones, which gives an undesirable taste and color and also decreases the availability of certain essential amino acids as well as the digestibility of the products. As such, highly effective tyrosinase inhibitors are also needed in agriculture and the food industry. Well known tyrosinase inhibitors include kojic acid, tropolone, coumarins, vanillic acid, vanillin, and vanillic alcohol.
Some academics, such as Stéphane Courtois (The Black Book of Communism), Steven Rosefielde (Red Holocaust), and Rudolph Rummel (Death by Government), wrote of mass, excess deaths under Marxist–Leninist regimes. These authors defined the political repression by communists as a "Communist democide", "Communist genocide", "Red Holocaust", or followed the "victims of Communism" narrative. Some of them compared Communism to Nazism and described deaths under Marxist–Leninist regimes (civil wars, deportations, famines, repressions, and wars) as being a direct consequence of Marxism–Leninism. Some of these works, in particular The Black Book of Communism and its 93 or 100 millions figure, are cited by political groups and Members of the European Parliament. Without denying the tragedy of the events, other scholars criticise the interpretation that sees communism as the main culprit as presenting a biased or exaggerated anti-communist narrative. Several academics propose a more nuanced analysis of Marxist–Leninist rule, stating that anti-communist narratives have exaggerated the extent of political repression and censorship in communist states and drawn comparisons with what they see as atrocities that were perpetrated by capitalist countries, particularly during the Cold War. These academics include Mark Aarons, Noam Chomsky, Jodi Dean, Kristen Ghodsee, Seumas Milne, and Michael Parenti. Ghodsee, Nathan J.
== Natural types and subunit structure == The two principal gonadotropins in vertebrates are luteinizing hormone (LH) and follicle-stimulating hormone (FSH), although primates produce a third gonadotropin called chorionic gonadotropin (CG). LH and FSH are heterodimers consisting of two peptide chains, an alpha chain and a beta chain. LH and FSH share nearly identical alpha chains (about 100 amino acids long), whereas the beta chain provides specificity for receptor interactions. These subunits are heavily modified by glycosylation. The alpha subunit is common to each protein dimer (well conserved within species, but differing between them), and a unique beta subunit confers biological specificity. The alpha chains are highly conserved proteins of about 100 amino acid residues which contain ten conserved cysteines all involved in disulfide bonds, as shown in the following schematic representation.
GB patent 1472793, John B. Glen; Roger James & Bob-James Munroe, "Pharmaceutical Compositions", published 4 May 1977, assigned to Imperial Chemical Industries Ltd Archived 5 June 2021 at the Wayback Machine
Sources: en.wikipedia.org
The P/E-site holds the TRNA with the growing polypeptide chain. When an aminoacyl-TRNA initially binds to its corresponding codon on the mRNA, it is in the A site. Then, a peptide bond forms between the amino acid of the TRNA in the A site and the amino acid of the charged TRNA in the P/E site. The growing polypeptide chain is transferred to the TRNA in the A site. Translocation occurs, moving the TRNA to the P/E site, now without an amino acid; the TRNA that was in the A site, now charged with the polypeptide chain, is moved to the P/E site and the uncharged TRNA leaves, and another aminoacyl-TRNA enters the A site to repeat the process. After the new amino acid is added to the chain, and after the TRNA is released out of the ribosome and into the cytosol, the energy provided by the hydrolysis of a GTP bound to the translocase EEF2 moves the ribosome down one codon towards the 3' end. The energy required for translation of proteins is significant. For a protein containing n amino acids, the number of high-energy phosphate bonds required to translate it is 4n-1. The rate of translation varies; it is significantly higher in prokaryotic cells (up to 17–21 amino acid residues per second) than in eukaryotic cells (up to 6–9 amino acid residues per second).
Hyaluronic acid is one of the most common materials used for injectable filler procedures due to its natural presence in vertebrates. Its inherent biocompatibility and biodegradability makes it particularly well suited for these applications, contributing to its widespread use in aesthetic and medical treatments. The chemical structure of hyaluronic acid is made up of repeating disaccharide units that consist of N-acetyl-D-glucosamine and D-glucuronic acid. Crosslinking Mechanisms in Injectable Fillers Crosslinking mechanisms determine the mechanical stability, degradation behavior, prolonged in vivo retention time, and in situ gelation properties of the injectable filler material. Hydrogels used as injectable fillers may be formed through physical (non-covalent) interactions or chemical (covalent) crosslinking, with chemical crosslinking generally providing greater stability and tunability. In collagen-based fillers, crosslinking methods such as glutaraldehyde treatment have been used to enhance integration, while synthetic fillers like poly(methyl methacrylate) rely on particulate scaffolds that induce fibrotic tissue formation rather than on degradable networks. Among chemical approaches, enzymatic crosslinking has gained prominence for its ability to proceed under physiological conditions without toxic catalysts or external stimuli such as ultraviolet light. Common enzymatic crosslinking mechanisms include horseradish peroxidase (HRP), tyrosinase, and transglutaminase.
According to TMZ, he had been suffering from liver and kidney damage, which were believed to be the result of his addiction. In September 2006, Terrence Kiel, a San Diego Chargers player, was arrested during practice for the possession with intent to sell prescription cough syrup for use in making the drink. Kiel was caught trying to ship a case of syrup to a friend via FedEx. Kiel was charged with two felony counts of transporting a controlled substance and three counts of possession for sale of a controlled substance. On July 8, 2008, Johnny Jolly, a Green Bay Packers player, was pulled over in his car by the police for playing excessively loud music in a nightclub parking lot. The officers found a Dr Pepper bottle in a holder next to two Styrofoam cups containing soda and ice. The case was dismissed, but charges were refiled in December 2009 after the Houston Police Department acquired new equipment that allowed the police to test the evidence again. Jolly faced a possible maximum sentence of up to 20 years in jail, but as a first time offender he would be eligible for probation. On July 5, 2010, former Oakland Raiders quarterback JaMarcus Russell was arrested at his home in Mobile, Alabama, for possession of codeine without a prescription. He was arrested as part of an undercover narcotics investigation. Russell was booked into city jail and released soon afterwards after making his bail.
After the 1986 People Power Revolution that toppled the regime of President Ferdinand Marcos, Duterte was appointed officer-in-charge vice mayor of Davao City by President Corazon Aquino. In the 1988 local elections, he ran for mayor under Lakas ng Dabaw, a local political alliance, defeating former OIC Mayor Zafiro Respicio by a narrow margin of 6,000 votes. As mayor of Davao City, Duterte made efforts to unite the different tribes and political groups in the city. He set a precedent by designating deputy mayors to represent the administrative districts, as well as the Lumad and Moro peoples in the city government; this was later copied by other cities in other parts of the Philippines. In December 1990, Duterte joined the Nacionalista Party upon the persuasion of Senator Juan Ponce Enrile. In 1992, he successfully defended his seat from 1st district representative Prospero Nograles. In 1995, after Flor Contemplacion, a Filipina, was executed in Singapore after confessing to a double murder, Duterte allegedly burned a flag of Singapore (though this claim was later denied) and joined 1,000 employees of Davao City in protest. In 1998, because he was term-limited to run again for mayor, Duterte ran and won as congressman of the city's 1st district under Laban ng Makabayang Masang Pilipino. He was a member of five House committees, namely: National Defense, Public Order and Security, Health, Transportation and Communications, and Cooperative Development. He filed 64 measures, including 45 bills, with one enacted into law—Republic Act No.
She explained "For Ari, the attraction for Mac would be that he provides her with groundings. His energy allows her to feel safe and protected and I guess relaxed, because she can be quite a buzz in the brain, quite a stress head and that's something that really attracts her to his energy." Weir thought Ari was more likely to prioritise her, while Tane would bring too much drama and chaos into her life. Weir also told Kilkelly that as things between Ari and Mac become more serious, Mac finds that Tane is not "a temptation" and she can fully commit to Ari and their future. In scenes filmed in the Blue Mountains, Mac joins the brothers as they search for Nikau and his girlfriend Bella Nixon (Courtney Miller), who needs to return for a police interview. Weir said that Mac is pleased when Ari and Tane temporarily set aside their differences to find Nikau and Bella. While Mac is staying with the Paratas, Ari soon notices the tension between her and Tane. After Tane admits that he is struggling to be himself around Mac, she decides to move in with Ziggy Astoni (Sophie Dillman), just as Ari asks her to move in permanently. As Mac thinks the offer over, Ari runs out of patience and he questions whether she is as committed to their relationship as he is. Mac moves out and Ari takes his anger out on Tane, before his suspicions lead him to give Mac an ultimatum about the status of their relationship. The arrival of Ari's stepdaughter Chloe Anderson (Sam Barrett) and her mother Mia Anderson (Anna Samson) in February 2021 leads to the end of his relationship with Mac.
Sources: en.wikipedia.org
It is a synthetic peptide fragment derived from the C-terminal region of human growth hormone, commonly referred to as hGH fragment 176-191. It has been investigated for effects on fat metabolism, but it is not an approved medication in most jurisdictions.
No. It is a shortened peptide fragment, not the full hormone. It does not contain the entire hGH sequence and is studied for different proposed effects.
Regulatory approvals for weight loss are not established in major jurisdictions. Some human trials reported modest changes, but the evidence is limited, and it remains a research compound.
No major medicines regulator appears to have approved AOD-9604 for human therapeutic use. It has been studied in clinical trials, but those programs did not result in a marketed drug.